<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03056859</url>
  </required_header>
  <id_info>
    <org_study_id>Compass Device Trial</org_study_id>
    <nct_id>NCT03056859</nct_id>
  </id_info>
  <brief_title>Compass Device CVC Trial</brief_title>
  <official_title>Central Venous Catheterization in Obese Patients With Compass Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centurion Medical Products</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-arm observational trial of a device (Compass Vascular Access, Centurion&#xD;
      Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular&#xD;
      blood pressure transducer. This pressure measurement aids in confirmation of appropriate&#xD;
      venous access. The investigators plan to enroll 40 consenting patients with BMI ≥35 who&#xD;
      require central venous catheterization for clinical reasons independent of the existence of&#xD;
      this study. The primary outcome is operator satisfaction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty (40) consenting patients meeting inclusion/exclusion criteria for this single-arm&#xD;
      observational trial will be prepared as usual for central venous catheter (CVC) placement.&#xD;
      The Compass pressure measurement device will be included in the CVC placement apparatus as&#xD;
      per the manufacturer's directions. Data will be recorded on the placement procedure, operator&#xD;
      satisfaction, routine patient demographics, and incidence of inadvertent arterial puncture.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 17, 2017</start_date>
  <completion_date type="Actual">February 10, 2020</completion_date>
  <primary_completion_date type="Actual">February 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Operator Satisfaction</measure>
    <time_frame>15 minutes</time_frame>
    <description>Operator satisfaction (0-10 scale; 0=totally dissatisfied, 10=totally satisfied)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial puncture incidence</measure>
    <time_frame>15 minutes</time_frame>
    <description>Incidence of arterial puncture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implement used at time of arterial puncture, if any</measure>
    <time_frame>15 minutes</time_frame>
    <description>Incidence of artery puncture with either needle, guidewire, or catheter</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Enrolled Patients</arm_group_label>
    <description>Procedure: Central venous catheter placement with extravascular blood pressure transducer</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extravascular blood pressure transducer</intervention_name>
    <description>Listed device is included in central venous catheter placement apparatus for consenting patients, according to manufacturer directions</description>
    <arm_group_label>Enrolled Patients</arm_group_label>
    <other_name>Compass Vascular Access</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting at University of New Mexico main/adult operating rooms who require&#xD;
        central venous catheter (CVC) placement for perioperative care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI ≥35&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Adults unable to consent&#xD;
&#xD;
          -  Non-English speakers&#xD;
&#xD;
          -  Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neal Gerstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of New Mexico Hospital</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 14, 2017</study_first_submitted>
  <study_first_submitted_qc>February 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2017</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of New Mexico</investigator_affiliation>
    <investigator_full_name>Neal Gerstein</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Operator satisfaction with device</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Deidentified study data may be shared with other researchers, pending final decision by study PI and sponsor</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

